Sea Limited (SE) Reaches $12.30 After 8.00% Down Move; Tekla Capital Management Has Cut Novo Nordisk A/S (NVO) Holding

February 22, 2018 - By Nellie Frank

Tekla Capital Management Llc decreased Novo Nordisk A/S (NVO) stake by 66.13% reported in 2017Q3 SEC filing. Tekla Capital Management Llc sold 143,700 shares as Novo Nordisk A/S (NVO)’s stock rose 15.20%. The Tekla Capital Management Llc holds 73,600 shares with $3.54M value, down from 217,300 last quarter. Novo Nordisk A/S now has $122.25B valuation. The stock increased 2.82% or $1.455 during the last trading session, reaching $52.985. About 1.76M shares traded or 28.90% up from the average. Novo Nordisk A/S (NYSE:NVO) has declined 23.93% since February 22, 2017 and is downtrending. It has underperformed by 40.63% the S&P500.

The stock of Sea Limited (NYSE:SE) is a huge mover today! The stock decreased 1.76% or $0.22 during the last trading session, reaching $12.3. About 106,890 shares traded. Sea Limited (NYSE:SE) has 0.00% since February 22, 2017 and is . It has underperformed by 16.70% the S&P500.The move comes after 5 months negative chart setup for the $4.02 billion company. It was reported on Feb, 22 by We have $11.32 PT which if reached, will make NYSE:SE worth $321.84 million less.

Analysts await Novo Nordisk A/S (NYSE:NVO) to report earnings on May, 2. They expect $0.66 EPS, up 13.79% or $0.08 from last year’s $0.58 per share. NVO’s profit will be $1.52 billion for 20.07 P/E if the $0.66 EPS becomes a reality. After $0.53 actual EPS reported by Novo Nordisk A/S for the previous quarter, Wall Street now forecasts 24.53% EPS growth.

Among 15 analysts covering Novo Nordisk (ADR) (NYSE:NVO), 7 have Buy rating, 0 Sell and 8 Hold. Therefore 47% are positive. Novo Nordisk (ADR) had 21 analyst reports since August 28, 2015 according to SRatingsIntel. The stock of Novo Nordisk A/S (NYSE:NVO) has “Conviction Buy” rating given on Monday, February 15 by Goldman Sachs. The firm earned “Hold” rating on Monday, October 31 by DNB Markets. Bank of America upgraded Novo Nordisk A/S (NYSE:NVO) on Wednesday, September 6 to “Neutral” rating. The firm earned “Hold” rating on Wednesday, August 31 by HSBC. On Friday, December 1 the stock rating was upgraded by Morgan Stanley to “Overweight”. Citigroup downgraded the stock to “Neutral” rating in Monday, October 31 report. As per Friday, December 29, the company rating was upgraded by JP Morgan. Jyske Bank upgraded the stock to “Strong Buy” rating in Monday, October 19 report. The firm has “Hold” rating given on Friday, December 29 by J.P. Morgan. As per Monday, February 8, the company rating was downgraded by UBS.

Tekla Capital Management Llc increased Illumina Inc. (NASDAQ:ILMN) stake by 37,731 shares to 316,691 valued at $63.09 million in 2017Q3. It also upped Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) stake by 21,250 shares and now owns 148,558 shares. Wright Medical Group N.V. was raised too.

Sea Limited, an Internet platform company, engages in the digital entertainment, e-commerce, and digital financial service businesses in Greater Southeast Asia. The company has market cap of $4.02 billion. It provides Garena digital entertainment platform for users to access mobile and PC online games, and eSports operations; and access to other entertainment content, such as live streaming of online gameplay and social features. It currently has negative earnings. The firm also operates Shopee e-commerce platform, a third-party marketplace that connects buyers and sellers through the Shopee mobile app and Websites.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: